Prequalification Update - 06 June 2011

WHO Prequalification Programme publishes new WHO Public Assessment Reports (WHOPARs)

     The WHOPARs cover the following product:

• HA412:    Lopinavir/Ritonavir - 200mg/50mg - Film-coated tablets - Abbott GmbH & Co. KG - GERMANY

• HA434:    Lopinavir/Ritonavir - 100mg/25mg - Film-coated tablets - Abbott GmbH & Co. KG - GERMANY
  

Related Link:  Overview of WHOPARs of Prequalified Medicinal Products